Sign in to view content

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, MD FASRS

Video
Published 2016

Related

Advances in Diabetic Vitrectomy
Judy E. Kim, MD, FASRS
Updates from the Field
2016
Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results
Peter J. Kertes, MD, FRCS(C)
Updates from the Field
2018
Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more